Trauth J M, Musa D, Siminoff L, Jewell I K, Ricci E
Graduate School of Public Health, University of Pittsburgh, USA.
J Health Soc Policy. 2000;12(2):23-43. doi: 10.1300/J045v12n02_02.
The recruitment of adequate numbers of people to participate in medical research studies is an ongoing problem for biomedical researchers. Although the general public has come to expect and demand that the biomedical community develop new, safe and effective approaches to the prevention and treatment of diseases, that same public is not aware of the important role that public participation plays in the development of medical advances. Much is known about willingness to participate in research studies from the perspectives of patients, survivors, and those at-risk for getting a particular disease. However, little is known about the attitudes and willingness of the general public to participate in medical research. Yet, it is this population that comprises the potential pool of participants for future treatment and prevention studies. In order to examine public attitudes toward and support for medical research, a random digit dial telephone survey was conducted with 489 persons in southwestern Pennsylvania. The survey measured the respondent's stated willingness to take part in a medical research study and the factors associated with willingness to participate. These included the respondent's health status, demographic characteristics, attitudes and beliefs about participation and their knowledge about the conduct of medical research. The results of the study indicate that 46% of those surveyed said that they would be willing to take part in a medical research study focusing on a new treatment for a specific disease that was of concern to them, 25% stated that they would not be willing and 29% stated that they were undecided regarding participation. However, under certain circumstances, such as having cancer, over half of those who were undecided said they would be willing to participate. The characteristics of those willing to participate in a medical research study differ from those not willing. Determinants of willingness include: having a relative or friend who has an illness, being middle aged (between 35-64 years old), prior experience with participation in a medical research study, having a favorable attitude toward the use of human subjects in medical research and beliefs that diverse types of persons participate in clinical trials. Those respondents who were undecided about joining a clinical trial, also have different characteristics than those who are not willing. The determinants of being undecided in contrast to not willing include: having at least a college degree, having a favorable or neutral attitude toward the use of humans in medical research and, believing that the well-being of participants is the primary concern of researchers. The findings of this study have both public policy and practice implications. From a policy perspective, medical research designed to develop new treatments for disease requires an evidenced-based approach for decision making. Such an approach can only succeed if adequate numbers of individuals are willing to participate in these studies. From a practice perspective, the current study suggests that opportunities exist to increase participation by targeting recruitment efforts not only toward the willing but also toward those who are undecided about participation in medical research studies. This would involve tailoring the content of communications to meet the specific characteristics and concerns of each of these two groups of individuals.
招募足够数量的人参与医学研究对生物医学研究人员来说一直是个难题。虽然公众期望并要求生物医学界开发新的、安全有效的疾病预防和治疗方法,但公众并不了解公众参与在医学进步发展中所起的重要作用。从患者、幸存者以及患特定疾病风险人群的角度,我们对参与研究的意愿了解很多。然而,对于普通公众参与医学研究的态度和意愿却知之甚少。然而,正是这一群体构成了未来治疗和预防研究的潜在参与者库。为了研究公众对医学研究的态度和支持情况,对宾夕法尼亚州西南部的489人进行了随机数字拨号电话调查。该调查衡量了受访者表示参与医学研究的意愿以及与参与意愿相关的因素。这些因素包括受访者的健康状况、人口统计学特征、对参与的态度和信念以及他们对医学研究实施情况的了解。研究结果表明,46%的受访者表示他们愿意参与一项针对他们所关注的特定疾病新疗法的医学研究,25%的人表示不愿意,29%的人表示对参与与否不确定。然而,在某些情况下,比如患有癌症,超过一半原本不确定的人表示愿意参与。愿意参与医学研究的人与不愿意参与的人特征不同。愿意参与的决定因素包括:有亲属或朋友患病、中年(35 - 64岁之间)、有参与医学研究的既往经历、对医学研究中使用人体受试者持积极态度以及相信不同类型的人会参与临床试验。那些对是否参与临床试验犹豫不决的受访者,其特征也与不愿意参与的人不同。与不愿意参与相比,犹豫不决的决定因素包括:至少拥有大学学历、对医学研究中使用人体持积极或中立态度,以及相信参与者的福祉是研究人员的首要关注点。这项研究的结果对公共政策和实践都有影响。从政策角度来看,旨在开发疾病新疗法的医学研究需要基于证据的决策方法。只有足够数量的人愿意参与这些研究,这样的方法才能成功。从实践角度来看,当前研究表明存在增加参与度的机会,不仅要针对愿意参与的人,还要针对那些对参与医学研究犹豫不决的人进行招募。这将涉及调整沟通内容,以满足这两类人群各自的特定特征和关注点。